Literature DB >> 6701773

Neurosurgical management of single brain metastasis.

D Yardeni, E Reichenthal, G Zucker, A Rubeinstein, M Cohen, V Israeli, M N Shalit.   

Abstract

A series of 74 consecutive cases undergoing craniotomy for single brain metastasis in the Beilinson Medical Center between October 1975 and October 1981 were reviewed. All patients underwent radiation therapy after craniotomy. The most common metastasis was that of unknown origin (35%), followed by lung (24%) and breast (16%). Overall median survival after craniotomy was 6.6 months. Overall 1- and 2-year survival rates were 30 and 15%, respectively. Operative mortality (30 days) was 15%. For the patients with metastases to the lung, median survival was 7.5 months and 1-year survival rate was 33%. It appears from this report that two dominant factors affect the prognosis of these patients. The first is the long latent interval (time between diagnosis of primary tumor and detection of metastasis). The second is the location of the metastasis; those with lesions in the cerebral hemispheres had a far better outcome than those with cerebellar lesions (p less than 0.0001).

Entities:  

Mesh:

Year:  1984        PMID: 6701773     DOI: 10.1016/0090-3019(84)90118-6

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Prognostic evaluation before operative extirpation and radiotherapy of solitary brain metastasis.

Authors:  L Pellettieri; U Sjölander; K E Jakobsson
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

2.  Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.

Authors:  Kaisorn L Chaichana; Shami Acharya; Mariana Flores; Olindi Wijesekera; Daniele Rigamonti; Jon D Weingart; Alessandro Olivi; Chetan Bettegowda; Gary L Gallia; Henry Brem; Michael Lim; Alfredo Quinones-Hinojosa
Journal:  World Neurosurg       Date:  2013-09-25       Impact factor: 2.104

Review 3.  Surgical treatment of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; A K Bindal; R K Bindal; K R Hess
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

4.  Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases.

Authors:  D J Stewart; L Eapen; A Girard; S Verma; P Genest; W K Evans
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

Review 5.  Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.

Authors:  H Nakagawa; Y Miyawaki; T Fujita; S Kubo; K Tokiyoshi; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.